Marpai, Inc. (MRAI)
NASDAQ: MRAI · IEX Real-Time Price · USD
2.440
+0.360 (17.31%)
At close: Mar 28, 2024, 4:00 PM
2.290
-0.150 (-6.15%)
After-hours: Mar 28, 2024, 7:35 PM EDT
Company Description
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel.
The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services.
It also develops artificial intelligence and healthcare technology. Marpai, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Marpai, Inc.
Country | United States |
Founded | 2019 |
IPO Date | Oct 27, 2021 |
Industry | Healthcare Plans |
Sector | Healthcare |
Employees | 303 |
CEO | Damien Francis Lamendola |
Contact Details
Address: 615 Channelside Drive, Suite 207 Tampa, Florida 33602 United States | |
Phone | 646-303-3483 |
Website | marpaihealth.com |
Stock Details
Ticker Symbol | MRAI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $4.00 |
CIK Code | 0001844392 |
CUSIP Number | 571354109 |
ISIN Number | US5713542083 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Damien Francis Lamendola | Chief Executive Officer and Director |
Steve Johnson | Chief Financial Officer and Company Secretary |
Yaron I. Eitan | Co-Founder and Chairman of the Board |
John Powers | President and Chief Operating Officer |
Dr. Eli David | Co-Founder and Chief Science Advisor |
Pamela Burns | Vice President of Enterprise Sales |
Simon Li | Vice President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 26, 2024 | 10-K | Annual Report |
Mar 26, 2024 | 8-K | Current Report |
Mar 18, 2024 | PRE 14A | Other preliminary proxy statements |
Mar 14, 2024 | DEF 14A | Other definitive proxy statements |
Mar 13, 2024 | 8-K | Current Report |
Mar 11, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Mar 8, 2024 | 8-K | Current Report |
Mar 6, 2024 | 8-K/A | [Amend] Current report |
Mar 6, 2024 | 8-K | Current Report |
Mar 5, 2024 | 8-K | Current Report |